Beckman Coulter Profit Rises 19%; Ceradyne’s Falls
Beckman Coulter Inc., a Fullerton developer of laboratory instruments and supplies, Monday reported first-quarter net income of $28 million, or 43 cents a share, 19% higher than the $23.5 million, or 37 cents, posted for the same period last year.
Sales increased 3% to $446.7million.
Beckman’s chairman, John P. Wareham, noting that the markets the company is in are generally favorable, forecast second-quarter sales to grow about 6% and net earnings to jump as high as 19%.
The strongest-performing product lines last quarter were robotic automation and genetic analysis and immunodiagnostics. Robotic automation and genetic analysis sales grew 20%, while immunodiagnostics sales grew 8%.
Meanwhile, Costa Mesa-based Ceradyne Inc., a manufacturer of technical ceramics, said net income for the first quarter was $579,000, or 7cents a share, a 51% decline from $1.2 million, or 14 cents, for the first quarter of 2001.
Sales rose 24% to a record $14.7million.
*
James S. Granelli
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.